PREDICTION OF THE INFLUENCE OF ORIGINAL AND GENERIC ROSUVASTATIN ON DIRECT MEDICAL COSTS OF SECONDARY PREVENTION IN PATIENTS WITH CHRONIC TYPES OF ISCHEMIC HEART DISEASE

PREDICTION OF THE INFLUENCE OF ORIGINAL AND GENERIC ROSUVASTATIN ON DIRECT MEDICAL COSTS OF SECONDARY PREVENTION IN PATIENTS WITH CHRONIC TYPES OF ISCHEMIC HEART DISEASE

Aim. To study therapeutic equivalence of rosuvastatin generic and original medication and to conduct the pharmacoeconomic analysis to compare the impact of the drug on direct expenses in secondary prevention for the patients with chronic ischemic heart disease (CHD). Material and methods. The open l...

Full description

Bibliographic Details
Main Authors:	E. I. Tarlovskaya, G. I. Nechaeva, S. V. Malchikova, А. А. Semenkin
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2015-08-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	розувастатин стабильная ишемическая болезнь сердца терапевтическая эквивалентность фармакоэкономиче ский анализ
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/244

Similar Items

Rosuvastatin safety and efficacy in coronary heart disease patients
by: I. V. Sergienko, et al.
Published: (2006-10-01)

Effect of medication adherence on the risk of cardiovascular events in outpatients with stable coronary artery disease: results of two-year monitoring
by: S. B. Fitilev, et al.
Published: (2023-04-01)

EFFECT OF ROSUVASTATIN ON CAROTID INTIMAMEDIA THICKNESS IN PATIENTS WITH CORONARY ARTERY DISEASE OF DIFFERENT GENDER AND CARDIOVASCULAR RISK PROFILE
by: S. I. Kononov, et al.
Published: (2018-05-01)

Apolipoprotein E gene polymorphisms: a relationship with the risk of coronary artery disease and the effectiveness of lipid-lowering therapy with rosuvastatin
by: M. I. Churilin, et al.
Published: (2020-03-01)

Stable coronary heart disease treatment: focus on beta-adrenoblockers
by: V. I. Makolkin
Published: (2008-12-01)

Causes of shortness of breath in patients with stable coronary heart disease
by: S. F. Yarmedova, et al.
Published: (2022-10-01)

New potential of Trimetazidine MB for coronary heart disease treatment in the real-world clinical practice: results of the Russian multi-centre randomised study PERSPECTIVE (Part II)
by: M. G. Bubnova, et al.
Published: (2011-12-01)

Nitrates in complex angina management during the age of aggressive coronary atherosclerosis treatment
by: D. M. Aronov, et al.
Published: (2005-10-01)

Multivariate analysis of medication adherence among outpatients with stable coronary artery disease
by: S. B. Fitilev, et al.
Published: (2022-02-01)

The quality of received drug therapy in patients with stable coronary heart disease according to the ALIGN (TherApy in stabLe Coronary Artery dIsease Patients According to Clinical GuideliNes) study
by: E. D. Zharkova, et al.
Published: (2022-10-01)

Various protocols of extracorporeal shock wave therapy in the treatment of stable angina
by: M. M. Shcherbak, et al.
Published: (2019-11-01)

Importance of early diagnostics of chronic obstructive pulmonary disease in patients with coronary heart disease
by: A. N. Kuznetsov, et al.
Published: (2011-06-01)

Possibilities of atorvastatin loading dose using for the prevention of perioperative myocardial damage in patients with stable coronary artery disease
by: A. S. Ragozina, et al.
Published: (2019-11-01)

HIGH SELECTIVE LONG-ACTING Β1-BLOCKER WITH A VASODILATING EFFECT NEBIVOLOL IN PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE
by: V. P. Lupanov
Published: (2015-12-01)

Effects of Pharmacy Care Program on medication adherence in outpatients with stable coronary artery disease: a randomized controlled study
by: S. B. Fitilev, et al.
Published: (2022-01-01)

ДЖЕНЕРИЧЕСКИЕ СТАТИНЫ В КЛИНИЧЕСКОЙ ПРАКТИКЕ: ДЕШЕВЫЕ ЗАМЕНИТЕЛИ ИЛИ ДОСТОЙНАЯ АЛЬТЕРНАТИВА БРЕНДАМ. АТОРВАСТАТИН
by: В. П. Михин, et al.
Published: (2012-04-01)

EVALUATION OF RANOLAZINE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND CHRONIC STABLE ANGINA. RESULTS FROM THE TERISA RANDOMIZED CLINICAL TRIAL (TYPE 2 DIABETES EVALUATION OF RANOLAZINE IN SUBJECTS WITH CHRONIC STABLE ANGINA)
Published: (2015-09-01)

Predictors of long term adverse events after scheduled endovascular coronary interventions
by: E. O. Vershinina, et al.
Published: (2018-08-01)

Clinico-angiographic parallels in patients with coronary atherosclerosis risk factors
by: A. I. Koryakov
Published: (2006-06-01)

Suture annuloplasty for surgical treatment of ischemic mitral regurgitation: long-term results
by: М. Л. Гордеев, et al.
Published: (2015-10-01)

COMPLEX APPROACHES TO TREATMENT OF DYSLIPIDEMIA IN PATIENTS WITH ISHEMIC HEART DISEASE
by: M. A. Chichkova, et al.
Published: (2015-10-01)

Eurasian Guidelines for the diagnostics and management of stable coronary artery disease (2020-2021)
by: Yu. A. Karpov, et al.
Published: (2021-09-01)

LIFE QUALITY ASSESSMENT OF PATIENTS WITH STABLE CORONARY ARTERY DISEASE AFTER MYOCARDIAL REVASCULARIZATION
by: I. A. Narkevich, et al.
Published: (2021-05-01)

Novyy predstavitel' klassa statinov - krestor: vozmozhnosti v lechenii bol'nykh s metabolicheskim sindromom
by: I E Chazova, et al.
Published: (2006-03-01)

Prevalence of ischemic heart disease among males with tuberculosis
by: V A Koshechkin, et al.
Published: (2011-09-01)

СИСТЕМНЫЙ АНАЛИЗ В СОВРЕМЕННОЙ МЕТОДОЛОГИИ
by: В. С. Хазов
Published: (2012-10-01)

Результаты исследования EUROPA
Published: (2018-06-01)

О ФАКТОРАХ РИСКА, ОСОБЕННОСТЯХ ТЕЧЕНИЯ И КРИТЕРИЯХ ДИАГНОСТИКИ ИШЕМИЧЕСКОЙ БОЛЕЗНИ ПОЧЕК У БОЛЬНЫХ ИШЕМИЧЕСКОЙ БОЛЕЗНЬЮ СЕРДЦА
by: О. Н. Сигитова, et al.
Published: (2013-10-01)

ENDOTHELIAL DYSFUNCTION IN STABLE ANGINA AND MYOCARDIAL INFARCTION COMBINED WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: M. A. Popova, et al.
Published: (2015-12-01)

Место эхокардиографии с физической нагрузкой в диагностике стабильной ишемической болезни сердца: современное состояние вопроса
by: А. Таркова, et al.
Published: (2020-09-01)

CARDIOPROTECTIVE EFFECT OF PHYSICAL REHABILITATION IN PATIENTS WITH ISCHEMIC-ORIGIN DIASTOLIC DYSFUNCTION AFTER PERCUTANEOUS CORONARY INTERVENTION
by: N. P. Lyamina, et al.
Published: (2015-12-01)

Generic therapy: the problem of choice
by: S. N. Tolpygina
Published: (2009-06-01)

PROBLEM OF GENERIC REPLACEMENT: ADVANTAGES AND DISADVANTAGES
by: S. N. Tolpygina, et al.
Published: (2016-01-01)

КЛИНИКО-ГЕМОДИНАМИЧЕСКАЯ ХАРАКТЕРИСТИКА ЭФФЕКТИВНОСТИ ЭРАДИКАЦИОННОЙ ТЕРАПИИ У БОЛЬНЫХ С СОЧЕТАНИЕМ ИШЕМИЧЕСКОЙ БОЛЕЗНИ СЕРДЦА И ЯЗВЕННОЙ БОЛЕЗНИ
by: Ж. Г. Симонова, et al.
Published: (2014-10-01)

THE PROBLEM OF INTERCHANGEABILITY OF DRUG PRODUCTS. TRIMETAZIDINE IS AN EFFECTIVE TREATMENT OF PATIENTS WITH ISCHEMIC HEART DISEASE
by: L. E. Chekuldaeva, et al.
Published: (2015-12-01)

Respiratory function in patients with coronary heart disease in combination with chronic obstructive pulmonary disease
by: А. С. Клинкова, et al.
Published: (2015-10-01)

OBSTRUCTIVE CORONARY ATHEROSCLEROSIS AND ISCHEMIC HEART DISEASE: AN ELUSIVE LINK!
by: M. Marzilli, et al.
Published: (2015-12-01)

Риск развития осложнений при коронарном шунтировании с учетом эффективности легочной вентиляции
by: О. В. Каменская, et al.
Published: (2015-10-01)

Prospective rAndomized, single-blind, mulTicenter control clinical study of sirolimus-eluting coRonary stent “Calypso” vs everolimus-elutIng cOronary stenT “Xience Prime”: design and rationale for “PATRIOT” trial
by: А. А. Прохорихин, et al.
Published: (2016-12-01)

The effect of use simvastatin at treatment of ischemic heart disease patients of senile age
by: A. L. Pirogov, et al.
Published: (2007-10-01)